LEDGINs, non-catalytic site inhibitors of HIV-1 integrase: a patent review (2006 - 2014)
{{output}}
Introduction: Integration of the viral genome into the host cell chromatin is a central step in the replication cycle of the HIV. Blocking the viral integrase (IN) enzyme therefore provides an attractive therapeutic strategy, as ... ...
